Imuran-induced regression of plasma cell tumor MOPC-315

Family therapy trainees' evaluations of their best and worst supervision experiences.

Journal of marital and family therapy·2000

Pituitary extract causes aggregation and differentiation of rat mammary tumor MTW9/Pl cells.

Endocrinology·1992

The effect of dihydrotestosterone and culture conditions on proliferation of the human prostatic cancer cell line LNCaP.

Steroids·1992

Differential effects of LHRH and somatostatin analogs on human breast cancer.

The Journal of surgical research·1992

Role of prolactin in growth of the rat mammary tumor MTW9.

International journal of cancer·1991

Serum of patients with prostatic cancer or benign prostatic hypertrophy contains nonpolar testosterone.

Steroids·1990

Single-Cell Analysis Guides Organoid CRISPR Screening to Reveal NF1 as a Gatekeeper of Cervical Squamous Malignant Transformation.

Cancer research·2026

Varying Cancer Drug Doses to Balance Tumor Control and Resistance Evolution.

Cancer research·2026

Epigenetic Repression of Type I Interferon Signaling by RUNX2 Drives Immune Checkpoint Blockade Resistance in Osteosarcoma.

Cancer research·2026

The Trispecific Antibody IBI3019 Integrates CDH17-Enhanced EGFR Antagonism with Optimized CD16A Engagement to Elicit Potent Antitumor Activity with Minimal Toxicity.

Cancer research·2026

Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer.

Cancer research·2026

Neutrophil Extracellular Trap-Derived DNA Activates the ITGB1/FAK Pathway to Promote Lung Adenocarcinoma Metastasis.

Cancer research·2026

Reversing Dysfunction of CCR9+ Regulatory T Cells by Targeting the IL-21/IL-17 Axis Improves Type 1 Diabetes.

Diabetes, metabolic syndrome and obesity : targets and therapy·2026

The Patient With Multiple Alloantibodies: A Systematic Strategy for Antibody Identification and Transfusion Management.

Case reports in immunology·2026

Efficacy and safety of bispecific antibodies versus other antitumor therapies in solid tumors: a systematic review and meta-analysis.

Frontiers in immunology·2026

Global development of bispecific antibodies in oncology: a bibliometric analysis of geographic disparities, collaborative models, and emerging translational strategies.

Frontiers in immunology·2026

Quality improvement project - Implementation of subcutaneous immunoglobulin in patients with haematological disorders and secondary immunodeficiency.

Therapeutic advances in hematology·2026

Development of immune-related adverse events is associated with improved survival outcomes in cancer patients receiving immune checkpoint inhibitors.

Frontiers in immunology·2026

Related Experiment Videos

Imuran-induced regression of plasma cell tumor MOPC-315

Related Concept Videos

Family therapy trainees' evaluations of their best and worst supervision experiences.

Pituitary extract causes aggregation and differentiation of rat mammary tumor MTW9/Pl cells.

The effect of dihydrotestosterone and culture conditions on proliferation of the human prostatic cancer cell line LNCaP.

Differential effects of LHRH and somatostatin analogs on human breast cancer.

Role of prolactin in growth of the rat mammary tumor MTW9.

Serum of patients with prostatic cancer or benign prostatic hypertrophy contains nonpolar testosterone.

Single-Cell Analysis Guides Organoid CRISPR Screening to Reveal NF1 as a Gatekeeper of Cervical Squamous Malignant Transformation.

Varying Cancer Drug Doses to Balance Tumor Control and Resistance Evolution.

Epigenetic Repression of Type I Interferon Signaling by RUNX2 Drives Immune Checkpoint Blockade Resistance in Osteosarcoma.

The Trispecific Antibody IBI3019 Integrates CDH17-Enhanced EGFR Antagonism with Optimized CD16A Engagement to Elicit Potent Antitumor Activity with Minimal Toxicity.

Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer.

Neutrophil Extracellular Trap-Derived DNA Activates the ITGB1/FAK Pathway to Promote Lung Adenocarcinoma Metastasis.

Reversing Dysfunction of CCR9+ Regulatory T Cells by Targeting the IL-21/IL-17 Axis Improves Type 1 Diabetes.

The Patient With Multiple Alloantibodies: A Systematic Strategy for Antibody Identification and Transfusion Management.

Efficacy and safety of bispecific antibodies versus other antitumor therapies in solid tumors: a systematic review and meta-analysis.

Global development of bispecific antibodies in oncology: a bibliometric analysis of geographic disparities, collaborative models, and emerging translational strategies.

Quality improvement project - Implementation of subcutaneous immunoglobulin in patients with haematological disorders and secondary immunodeficiency.

Development of immune-related adverse events is associated with improved survival outcomes in cancer patients receiving immune checkpoint inhibitors.

Related Experiment Videos

Imuran-induced regression of plasma cell tumor MOPC-315

Related Concept Videos

Related Articles